(Q36611534)

English

Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

scientific article published on July 2006

Statements

Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. (English)
J Cummings
M Ranson
E Lacasse
J R Ganganagari
M St-Jean
J Durkin
1 July 2006
42-48

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit